Notice2025-00389
Meeting of the Advisory Commission on Childhood Vaccines
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 10, 2025
Issuing agencies
Health and Human Services DepartmentHealth Resources and Services Administration
Abstract
In accordance with the Federal Advisory Committee Act, this notice announces that the Advisory Commission on Childhood Vaccines (ACCV) has scheduled a public meeting. Information about ACCV and the agenda for this meeting can be found on the ACCV website at https:// www.hrsa.gov/advisory-committees/vaccines/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 90 Issue 6 (Friday, January 10, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 6 (Friday, January 10, 2025)]
[Notices]
[Page 2010]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-00389]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Meeting of the Advisory Commission on Childhood Vaccines
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, this
notice announces that the Advisory Commission on Childhood Vaccines
(ACCV) has scheduled a public meeting. Information about ACCV and the
agenda for this meeting can be found on the ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/index.html">https://www.hrsa.gov/advisory-committees/vaccines/index.html</a>.
DATES: The ACCV meeting will be held on January 29, 2025, 12 p.m.
eastern time (ET)-4 p.m. ET and January 30, 2025, 12 p.m. ET-4 p.m. ET.
ADDRESSES: The meeting will be held by Zoom webinar. For meeting
information updates and instructions for joining remote meetings, go to
the ACCV website meeting page at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>.
FOR FURTHER INFORMATION CONTACT: Pita Gomez, Principal Staff Liaison,
Division of Injury Compensation Programs, HRSA, 5600 Fishers Lane, 8W-
25A, Rockville, Maryland 20857; 800-338-2382; or <a href="/cdn-cgi/l/email-protection#2a6b69697c6a4258594b044d455c"><span class="__cf_email__" data-cfemail="9ddcdedecbddf5efeefcb3faf2eb">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: ACCV provides advice and recommendations to
the Secretary of Health and Human Services on policy, program
development, and other matters of significance related to
implementation of the National Vaccine Injury Compensation Program and
concerning other matters as described under section 2119 of the Public
Health Service Act (42 U.S.C. 300aa-19).
Since priorities dictate meeting times, be advised that start
times, end times, and agenda items are subject to change. Refer to the
ACCV website listed above for any meeting updates that may occur. For
the January 2025 meeting, agenda items may include, but are not limited
to: updates from the Division of Injury Compensation Programs,
Department of Justice, Office of Infectious Disease and HIV/AIDS Policy
(Department of Health and Human Services), Immunization Safety Office
(Centers for Disease Control and Prevention), National Institute of
Allergy and Infectious Diseases (National Institutes of Health), and
Center for Biologics Evaluation and Research (Food and Drug
Administration). Refer to the ACCV website listed above for all current
and updated information concerning the January 2025 ACCV meeting,
including the draft agenda that will be posted 15 calendar days before
the meeting.
This meeting is open to the public and requires registration.
Registration details will be provided on our ACCV website at <a href="https://www.hrsa.gov/advisory-committees/vaccines/meetings.html">https://www.hrsa.gov/advisory-committees/vaccines/meetings.html</a>. All
registrants will be asked to provide their name, affiliation, and email
address. After registration, individuals will receive personalized Zoom
information via email.
Members of the public will have the opportunity to provide
comments. Public participants may submit written statements in advance
of the meeting. Oral comments will be honored in the order they are
requested and may be limited as time allows. Requests to submit a
written statement or make oral comments to ACCV should be sent to Pita
Gomez using the contact information above at least 5 business days
before the meeting date.
Individuals who need special assistance or another reasonable
accommodation should notify Pita Gomez using the contact information
listed above at least 10 business days before the meeting.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2025-00389 Filed 1-8-25; 8:45 am]
BILLING CODE 4165-15-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 10, 2025.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.